CTOs on the Move

GitLab

www.gitlab.com

 
GitLab is a complete DevOps platform, delivered as a single application, fundamentally changing the way Development, Security, and Ops teams collaborate and build software. From idea to production, GitLab helps teams improve cycle time from weeks to minutes, reduce development costs and time to market while increasing developer productivity. We`re the world`s largest all-remote company with team members located in more than 65 countries. As part of the GitLab team, you can work from anywhere with good internet. You`ll have the freedom to contribute when and where you do your best work.
  • Number of Employees: 5K-10K
  • Annual Revenue: $250-500 Million
  • www.gitlab.com
  • 268 Bush Street
    San Francisco, CA USA 94104
  • Phone: 415.761.1791

Executives

Name Title Contact Details
Sabrina Farmer
 Chief Technology Officer Profile
Joel Krooswyk
 Federal Chief Technology Officer Profile
Josh Lemos
 Chief Information Security Officer Profile
Julia Lake
 Director of SecurityRisk and Compliance Profile
Francis Ofungwu
 Global Field CISO Profile

Funding

GitLab raised $100M on 09/19/2018
GitLab raised $268M on 09/19/2019

Similar Companies

Blip.tv

Blip.tv is a New York, NY-based company in the Software and Internet sector.

Software Sentinel

Software Sentinel is a Holden, MA-based company in the Software and Internet sector.

Altour IM

Altour IM is a Mesa, AZ-based company in the Software and Internet sector.

Forms Plus Inc

Forms Plus Inc is a Albuquerque, NM-based company in the Software and Internet sector.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.